These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 34167552)

  • 21. Chitosan-Based Nanoparticles with Optimized Parameters for Targeted Delivery of a Specific Anticancer Drug-A Comprehensive Review.
    Kurczewska J
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marine Polysaccharides in Pharmaceutical Applications: Fucoidan and Chitosan as Key Players in the Drug Delivery Match Field.
    Barbosa AI; Coutinho AJ; Costa Lima SA; Reis S
    Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31766498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
    Yanar F; Carugo D; Zhang X
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of Nanomedicine in Tumor Spheroid as an
    Roy SM; Garg V; Barman S; Ghosh C; Maity AR; Ghosh SK
    Front Bioeng Biotechnol; 2021; 9():785937. PubMed ID: 34926430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.
    Rajitha P; Gopinath D; Biswas R; Sabitha M; Jayakumar R
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1177-94. PubMed ID: 27087148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan Nanomedicine in Cancer Therapy: Targeted Delivery and Cellular Uptake.
    Mushtaq A; Li L; A A; Grøndahl L
    Macromol Biosci; 2021 May; 21(5):e2100005. PubMed ID: 33738977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.
    Shim S; Yoo HS
    Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates.
    Virmani T; Kumar G; Sharma A; Pathak K; Akhtar MS; Afzal O; Altamimi ASA
    Polymers (Basel); 2023 Jul; 15(13):. PubMed ID: 37447573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine.
    Ravindran S; Suthar JK; Rokade R; Deshpande P; Singh P; Pratinidhi A; Khambadkhar R; Utekar S
    Curr Drug Metab; 2018; 19(4):327-334. PubMed ID: 29512450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticles loaded with pharmacologically active plant-derived natural products: Biomedical applications and toxicity.
    Peng S; Wang Y; Sun Z; Zhao L; Huang Y; Fu X; Luo R; Xue J; Yang S; Ling L; Zhang Z
    Colloids Surf B Biointerfaces; 2023 May; 225():113214. PubMed ID: 36893664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicine: Bioavailability, Biotransformation and Biokinetics.
    Ravindran S; Tambe AJ; Suthar JK; Chahar DS; Fernandes JM; Desai V
    Curr Drug Metab; 2019; 20(7):542-555. PubMed ID: 31203796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook.
    Singh N; Shi S; Goel S
    Adv Drug Deliv Rev; 2023 Jan; 192():114638. PubMed ID: 36462644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of Isorhamnetin Nanoparticles and Their Targeting Efficiency to Nasopharynx Cancer.
    Yang B; Zhang F; Yuan W; Du L; Jiang X
    J Nanosci Nanotechnol; 2021 Feb; 21(2):1293-1299. PubMed ID: 33183475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer].
    Skaličková S; Gargulák M; Löffelmann M; Ruttkay-Nedecký B; Kepinská M; Parák T; Kizek R
    Klin Onkol; 2017; 30(Supplementum1):174-176. PubMed ID: 28471199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Overview of Chitosan Nanofibers and their Applications in the Drug Delivery Process.
    Al-Jbour ND; Beg MD; Gimbun J; Alam AKMM
    Curr Drug Deliv; 2019; 16(4):272-294. PubMed ID: 30674256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The implications of recent advances in carboxymethyl chitosan based targeted drug delivery and tissue engineering applications.
    Upadhyaya L; Singh J; Agarwal V; Tewari RP
    J Control Release; 2014 Jul; 186():54-87. PubMed ID: 24806482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery.
    Zacaron TM; Silva MLSE; Costa MP; Silva DME; Silva AC; Apolônio ACM; Fabri RL; Pittella F; Rocha HVA; Tavares GD
    Polymers (Basel); 2023 Sep; 15(18):. PubMed ID: 37765701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.